license

Regeneron Provides Update on EYLEA HD (aflibercept) Injection 8 mg Supplemental Biologics License ApplicationRegeneron Provides Update on EYLEA HD (aflibercept) Injection 8 mg Supplemental Biologics License Application

Regeneron Provides Update on EYLEA HD (aflibercept) Injection 8 mg Supplemental Biologics License Application

TARRYTOWN, N.Y., April 18, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and…

4 days ago
Danish Government awards Norne Thorning Storage the License to explore the possibility of CO2 storage in JutlandDanish Government awards Norne Thorning Storage the License to explore the possibility of CO2 storage in Jutland

Danish Government awards Norne Thorning Storage the License to explore the possibility of CO2 storage in Jutland

COPENHAGEN, Denmark, April 11, 2025 /PRNewswire/ -- Norne Thorning Storage ApS ("Norne"), a Fidelis New Energy, LLC company, has been awarded…

2 weeks ago
EnKash Secures Prestigious PPI License, Strengthening Its Leadership in Corporate Cards and Spend ManagementEnKash Secures Prestigious PPI License, Strengthening Its Leadership in Corporate Cards and Spend Management

EnKash Secures Prestigious PPI License, Strengthening Its Leadership in Corporate Cards and Spend Management

MUMBAI, India, April 9, 2025 /PRNewswire/ -- EnKash, India's pioneering spend management and payments platform, has secured the coveted Prepaid Payment…

2 weeks ago
ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative DiseasesABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases

ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases

- ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases - Programs will…

2 weeks ago
XRP Price Has 46% Upside Potential After Ripple’s Acquisition of First Dubai License, This AI-Powered Cloud Mining Platform PredictsXRP Price Has 46% Upside Potential After Ripple’s Acquisition of First Dubai License, This AI-Powered Cloud Mining Platform Predicts

XRP Price Has 46% Upside Potential After Ripple’s Acquisition of First Dubai License, This AI-Powered Cloud Mining Platform Predicts

Middlesex, UK, March 28, 2025 (GLOBE NEWSWIRE) -- One of the most lucrative but lesser-used methods is cloud mining, whereby…

4 weeks ago
MANTRA Secures First VARA DeFi License, Paving the Way for Global Growth and Innovation in Financial ProductsMANTRA Secures First VARA DeFi License, Paving the Way for Global Growth and Innovation in Financial Products

MANTRA Secures First VARA DeFi License, Paving the Way for Global Growth and Innovation in Financial Products

DUBAI, UAE, Feb. 19, 2025 /PRNewswire/ -- MANTRA Finance FZE (MANTRA), a leading decentralized finance (DeFi) platform operated by MANTRA Group,…

2 months ago
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug ConjugateRadiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate

Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate

BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced…

2 months ago
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in OncologyMenarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,…

3 months ago
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in OncologyMenarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,…

3 months ago
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in OncologyMenarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,…

3 months ago